Loading...
Medtronic reported revenue growth of 2.5% YoY, with strong performance in Pulsed Field Ablation, Neuromodulation, and Diabetes. Adjusted EPS grew 7% YoY, driven by operating margin expansion. The company reiterated its full-year guidance.
Revenue grew 2.5% YoY to $8.29 billion (+4.1% organic).
Adjusted EPS increased 7% YoY to $1.39.
Strong growth in Pulsed Field Ablation, Neuromodulation, and Diabetes.
Operating margin improved to 19.9% (+1.6pp YoY).
Medtronic reiterated its full-year revenue and EPS guidance, expecting continued organic growth and operational improvements.
Visualization of income flow from segment revenue to net income